Securities Litigation

C4 Therapeutics Presents Cemsidomide Phase 1 Multiple Myeloma Data Supporting …

September 20, 2025

This press release contains “forward-looking statements” of C4 Therapeutics, Inc., within the meaning of the Private Securities Litigation Reform Act …